193 related articles for article (PubMed ID: 20067553)
1. PAX3 and SOX10 activate MET receptor expression in melanoma.
Mascarenhas JB; Littlejohn EL; Wolsky RJ; Young KP; Nelson M; Salgia R; Lang D
Pigment Cell Melanoma Res; 2010 Apr; 23(2):225-37. PubMed ID: 20067553
[TBL] [Abstract][Full Text] [Related]
2. PAX3 and ETS1 synergistically activate MET expression in melanoma cells.
Kubic JD; Little EC; Lui JW; Iizuka T; Lang D
Oncogene; 2015 Sep; 34(38):4964-74. PubMed ID: 25531327
[TBL] [Abstract][Full Text] [Related]
3. PAX3 knockdown in metastatic melanoma cell lines does not reduce MITF expression.
He S; Li CG; Slobbe L; Glover A; Marshall E; Baguley BC; Eccles MR
Melanoma Res; 2011 Feb; 21(1):24-34. PubMed ID: 21164369
[TBL] [Abstract][Full Text] [Related]
4. Human melanocytes form a PAX3-expressing melanocyte cluster on Matrigel by the cell migration process.
Choi H; Jin SH; Han MH; Lee J; Ahn S; Seong M; Choi H; Han J; Cho EG; Lee TR; Noh M
J Dermatol Sci; 2014 Oct; 76(1):60-6. PubMed ID: 25128984
[TBL] [Abstract][Full Text] [Related]
5. Sox10 and Pax3 physically interact to mediate activation of a conserved c-RET enhancer.
Lang D; Epstein JA
Hum Mol Genet; 2003 Apr; 12(8):937-45. PubMed ID: 12668617
[TBL] [Abstract][Full Text] [Related]
6. Interaction among SOX10, PAX3 and MITF, three genes altered in Waardenburg syndrome.
Bondurand N; Pingault V; Goerich DE; Lemort N; Sock E; Le Caignec C; Wegner M; Goossens M
Hum Mol Genet; 2000 Aug; 9(13):1907-17. PubMed ID: 10942418
[TBL] [Abstract][Full Text] [Related]
7. Pax3 down-regulation and shut-off of melanogenesis in melanoma B16/F10.9 by interleukin-6 receptor signaling.
Kamaraju AK; Bertolotto C; Chebath J; Revel M
J Biol Chem; 2002 Apr; 277(17):15132-41. PubMed ID: 11830592
[TBL] [Abstract][Full Text] [Related]
8. Transcription factor hierarchy in Waardenburg syndrome: regulation of MITF expression by SOX10 and PAX3.
Potterf SB; Furumura M; Dunn KJ; Arnheiter H; Pavan WJ
Hum Genet; 2000 Jul; 107(1):1-6. PubMed ID: 10982026
[TBL] [Abstract][Full Text] [Related]
9. Temporally regulated neural crest transcription factors distinguish neuroectodermal tumors of varying malignancy and differentiation.
Gershon TR; Oppenheimer O; Chin SS; Gerald WL
Neoplasia; 2005 Jun; 7(6):575-84. PubMed ID: 16036108
[TBL] [Abstract][Full Text] [Related]
10. MEK inhibition remodels the active chromatin landscape and induces SOX10 genomic recruitment in BRAF(V600E) mutant melanoma cells.
Fufa TD; Baxter LL; Wedel JC; Gildea DE; ; Loftus SK; Pavan WJ
Epigenetics Chromatin; 2019 Aug; 12(1):50. PubMed ID: 31399133
[TBL] [Abstract][Full Text] [Related]
11. Activation of PAX3-MET pathways due to miR-206 loss promotes gastric cancer metastasis.
Zhang L; Xia L; Zhao L; Chen Z; Shang X; Xin J; Liu M; Guo X; Wu K; Pan Y; Fan D
Carcinogenesis; 2015 Mar; 36(3):390-9. PubMed ID: 25653235
[TBL] [Abstract][Full Text] [Related]
12. Expression of genes for microphthalmia isoforms, Pax3 and MSG1, in human melanomas.
Vachtenheim J; Novotná H
Cell Mol Biol (Noisy-le-grand); 1999 Nov; 45(7):1075-82. PubMed ID: 10644012
[TBL] [Abstract][Full Text] [Related]
13. SOX5 is involved in balanced MITF regulation in human melanoma cells.
Kordaß T; Weber CE; Oswald M; Ast V; Bernhardt M; Novak D; Utikal J; Eichmüller SB; König R
BMC Med Genomics; 2016 Feb; 9():10. PubMed ID: 26927636
[TBL] [Abstract][Full Text] [Related]
14. A phosphatidylinositol 3-kinase-Pax3 axis regulates Brn-2 expression in melanoma.
Bonvin E; Falletta P; Shaw H; Delmas V; Goding CR
Mol Cell Biol; 2012 Nov; 32(22):4674-83. PubMed ID: 22988297
[TBL] [Abstract][Full Text] [Related]
15. FOXD3 Promotes PAX3 Expression in Melanoma Cells.
Kubic JD; Little EC; Kaiser RS; Young KP; Lang D
J Cell Biochem; 2016 Feb; 117(2):533-41. PubMed ID: 26252164
[TBL] [Abstract][Full Text] [Related]
16. The MITF-SOX10 regulated long non-coding RNA DIRC3 is a melanoma tumour suppressor.
Coe EA; Tan JY; Shapiro M; Louphrasitthiphol P; Bassett AR; Marques AC; Goding CR; Vance KW
PLoS Genet; 2019 Dec; 15(12):e1008501. PubMed ID: 31881017
[TBL] [Abstract][Full Text] [Related]
17. MITF and PAX3 Play Distinct Roles in Melanoma Cell Migration; Outline of a "Genetic Switch" Theory Involving MITF and PAX3 in Proliferative and Invasive Phenotypes of Melanoma.
Eccles MR; He S; Ahn A; Slobbe LJ; Jeffs AR; Yoon HS; Baguley BC
Front Oncol; 2013 Sep; 3():229. PubMed ID: 24062982
[TBL] [Abstract][Full Text] [Related]
18. Two novel mutations of PAX3 and SOX10 were characterized as genetic causes of Waardenburg Syndrome.
Yu Y; Liu W; Chen M; Yang Y; Yang Y; Hong E; Lu J; Zheng J; Ni X; Guo Y; Zhang J
Mol Genet Genomic Med; 2020 May; 8(5):e1217. PubMed ID: 32168437
[TBL] [Abstract][Full Text] [Related]
19. A PAX3/BRN2 rheostat controls the dynamics of BRAF mediated MITF regulation in MITF
Smith MP; Rana S; Ferguson J; Rowling EJ; Flaherty KT; Wargo JA; Marais R; Wellbrock C
Pigment Cell Melanoma Res; 2019 Mar; 32(2):280-291. PubMed ID: 30277012
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of α-Melanocyte-Stimulating Hormone-Induced Activation of the Pax3-MITF-Tyrosinase Axis by Sorghum Ethanolic Extract in B16F10 Melanoma Cells.
Lee DH; Ahn SS; Kim JB; Lim Y; Lee YH; Shin SY
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29865165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
